1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,140 | 2,250 | 20:12 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.08. | Careium AB: President & CEO Christian Walén steps down from his position and Peter Heuman appointed as interim CEO | 258 | GlobeNewswire (Europe) | Careium's Board of Directors and Careium's President and CEO Christian Walén have mutually agreed that Christian Walén steps down from the role of President and CEO, effective immediately.
"The Board... ► Artikel lesen | |
| CAREIUM Aktie jetzt für 0€ handeln | |||||
| 11.07. | Careium AB: Careium reports second quarter results 2025 | 142 | GlobeNewswire (Europe) | The second quarter in summary
Net sales decreased 11.9 percent to SEK 202.1 million (229.4)Reported net sales was negatively impacted with SEK 15.1 million by the accounting of financial leases in Sweden... ► Artikel lesen | |
| 13.06. | Careium AB: Bulletin from the extraordinary general meeting on 13 June 2025 of Careium AB (publ) | 130 | GlobeNewswire (Europe) | The extraordinary general meeting ("EGM") of Careium AB (publ), 559121-5875, (the "Company") took place today, 13 June 2025.
The EGM resolved on all proposed matters in accordance with previously published... ► Artikel lesen | |
| 24.04. | Careium AB: Careium reports first quarter results 2025 | 81 | GlobeNewswire (Europe) | The First Quarter in Summary
Net sales decreased 1.6 percent to SEK 207.4 million (210.7)Service sales increased 3.4 percent to SEK 160.3 million (155.0)Product sales decreased 15.5 percent to SEK 47.1... ► Artikel lesen | |
| 13.02. | Careium AB: Careium reports fourth quarter results 2024 | 478 | GlobeNewswire (Europe) | The Fourth Quarter in SummaryNet sales increased 14.8 percent to SEK 228.9 million (199.4)Service sales was SEK 165.9 million (154.1)Product sales was SEK 63.0 million (45.3)Gross margin increased to... ► Artikel lesen | |
| 25.10.24 | Careium AB: Careium reports third quarter results 2024 | 190 | GlobeNewswire (Europe) | The quarter in summary
Net sales amounted to SEK 201.7 million (217.3), a decrease of 7.2 percent, as sales cycles were affected by prolonged lifetime of analog (UK) and 2G/3G (SWE) networks
Service... ► Artikel lesen |
6 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,060 | +0,75 % | PTA-Adhoc: PORR AG: PORR vereinbart Erwerb des österreichischen Projektentwicklungsgeschäfts und Thermenbeteiligungen von Fresenius/VAMED | DJ PTA-Adhoc: PORR AG: PORR vereinbart Erwerb des österreichischen Projektentwicklungsgeschäfts und Thermenbeteiligungen von Fresenius/VAMED
Veröffentlichung von Insiderinformationen gemäß Artikel... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 47,320 | +0,23 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| THERMO FISHER | 453,85 | +0,41 % | What to Expect From Thermo Fisher's Q3 2025 Earnings Report | ||
| EUROFINS SCIENTIFIC | 61,44 | -0,29 % | Eurofins Scientific SE: Weekly Report on Share Repurchases from 06th October to 10th October 2025 | Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument ... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB erweitert Investitionen in Italien mit Eröffnung eines neuen Vorzeige-Medizinzentrums in Florenz | EQS-News: SYNLAB
/ Schlagwort(e): Expansion
SYNLAB erweitert Investitionen in Italien mit Eröffnung eines neuen Vorzeige-Medizinzentrums in Florenz
09.10.2025 / 15:00 CET/CEST
Für... ► Artikel lesen | |
| DAVITA | 106,30 | -0,42 % | Aktienmarkt: DaVita-Aktie tritt auf der Stelle (110,9548 €) | Wenig Kursbewegung zur Stunde bei der Aktie von DaVita . Das Wertpapier notiert derzeit bei 130,14 US-Dollar. Der Kurs der Aktie von DaVita zeigt sich aktuell kaum verändert im Vergleich zu der Schlussnotierung... ► Artikel lesen | |
| DENTSPLY SIRONA | 10,380 | +1,76 % | DENTSPLY SIRONA Inc.: Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization | CHARLOTTE, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced that Aldo M. Denti has been appointed Executive Vice President... ► Artikel lesen | |
| SMITH & NEPHEW | 15,455 | +1,38 % | Smith & Nephew Plc: Smith+Nephew announces new category I CPT code for its CARTIHEAL AGILI-C Cartilage Repair Implant | Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural... ► Artikel lesen | |
| SONIC HEALTHCARE | 11,986 | +1,94 % | Buy, hold, sell: ResMed, Sonic Healthcare, and Steadfast | ||
| DIASORIN | 74,52 | -0,90 % | DiaSorin Launches LIAISON TSH-R Ab Assay In CE Mark Countries | ROME (dpa-AFX) - DiaSorin S.p.A. (DIA.MI) on Friday announced the launch of its new LIAISON TSH-R Ab assay, now available in all countries recognizing the CE Mark.This test is designed to help... ► Artikel lesen | |
| PATTERSON COMPANIES | 27,400 | 0,00 % | Patterson Companies Completes Acquisition by Patient Square Capital | Robert Rajalingam Appointed Chief Executive Officer and to Board of Directors
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies ("Patterson" or the "Company"), a leading supplier of products... ► Artikel lesen | |
| FULGENT GENETICS | 19,000 | -2,06 % | Fulgent Genetics: A Risky Bet or a Hidden Gem? | ||
| PERSPECTIVE THERAPEUTICS | 4,320 | +2,86 % | BTIG initiates coverage on Perspective Therapeutics stock with Buy rating | ||
| IMPLANTICA | 5,240 | -10,27 % | Implantica completes FDA 100-Day Meeting for RefluxStop PMA application | VADUZ, Liechtenstein, Oct. 13, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative... ► Artikel lesen | |
| OMNICELL | 25,400 | -1,55 % | Reasons to Add Omnicell Stock to Your Portfolio Right Now |
CAREIUM AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 2,160 Euro und damit +0,93 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CAREIUM AB finden Sie auf Wallstreet Online.